3 reports

From that price standpoint, the efficacy delivery wasn' t enough.

  • Oncology
  • Japan
  • Demand
  • Gilead Sciences, Inc.
  • Remicade group

MESALAMINE IS ONE OF THE MOST EXTENSIVELY USED DRUG AMONGST ALL ##-ASA AGENTS.

  • Oncology
  • Italy
  • Japan
  • Demand
  • Remicade group

Firer MA and Gellerman G (2012) Targeted drug delivery for cancer therapy: the other side of antibodies.

  • Oncology
  • Italy
  • Japan
  • Demand
  • Gilead Sciences, Inc.